Merck KGaA (MRK) News Today €142.00 +0.65 (+0.46%) As of 01/20/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Merck price target lowered to $113 from $123 at Morgan StanleyJanuary 21 at 12:48 PM | markets.businessinsider.comAnalysts Are Neutral on These Healthcare Stocks: Inspire Medical Systems (INSP), Merck & Company (MRK)January 21 at 12:48 PM | markets.businessinsider.comWhat's In Store For Merck Stock In 2025?January 17, 2025 | forbes.comBerenberg Bank Remains a Buy on Merck & Company (MRK)January 15, 2025 | markets.businessinsider.comMerck & Co.’s Accelerated Keytruda Launch and Strategic Updates Bolster Long-term Growth ProspectsJanuary 14, 2025 | markets.businessinsider.comMerck Races to Launch Subcutaneous Keytruda Amid Looming Patent Expiry for IV VersionJanuary 14, 2025 | uk.finance.yahoo.comMerck KGaA (ETR:MRK) Shares Down 1.4% - What's Next?Merck KGaA (ETR:MRK) Shares Down 1.4% - Here's WhyJanuary 10, 2025 | marketbeat.comEQS-AFR: Merck KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statementsJanuary 9, 2025 | markets.businessinsider.comMerck’s Gardasil receives expanded approval for males in ChinaJanuary 8, 2025 | markets.businessinsider.comMerck downgraded to Hold from Buy at TruistJanuary 7, 2025 | markets.businessinsider.comTruist Financial downgrades Merck & Company (MRK) to a HoldJanuary 7, 2025 | markets.businessinsider.comUnpacking the Latest Options Trading Trends in Merck & CoJanuary 7, 2025 | benzinga.comWuxi Biologics to sell Irish vaccine facility to Merck for $500M, Reuters saysJanuary 7, 2025 | markets.businessinsider.comMerck launches first-to-market, cyber-physical trust platform to tackle issues of product safety and counterfeitingJanuary 7, 2025 | finanznachrichten.deMerck KGaA, Darmstadt, Germany, launches first-to-market, cyber-physical trust platform to tackle issues of product safety and counterfeitingJanuary 7, 2025 | tmcnet.comMerck put volume heavy and directionally bearishJanuary 2, 2025 | markets.businessinsider.comMerck’s sotatercept approved by MHRA to treat PAHDecember 31, 2024 | markets.businessinsider.comMerck KGaA's (ETR:MRK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?December 26, 2024 | finance.yahoo.comMerck closes exclusive global license agreement for LM-299 from LaNova MedicinesDecember 20, 2024 | markets.businessinsider.comBMO Capital Downgrades Merck (MRK)December 20, 2024 | msn.comMerck Reports Topline Data From Phase 3 Trials Of Doravirine + Islatravir To Treat HIV-1 InfectionDecember 19, 2024 | markets.businessinsider.comMerck: FDA To Review BLA For Clesrovimab - Quick FactsDecember 17, 2024 | markets.businessinsider.comMerck announces approval of KEYTRUDA in China in combination with chemotherapyDecember 16, 2024 | markets.businessinsider.comMerck announces CHMP opinion recommending conditional approval of WeliregDecember 13, 2024 | markets.businessinsider.comMerck gets positive EU regulatory opinion for WeliregDecember 13, 2024 | msn.comBoulder drug discovery co. attracts Merck as an investorDecember 11, 2024 | bizjournals.comIs Merck & Co., Inc. (MRK) the Best American Dividend Stock to Buy Right Now?December 11, 2024 | msn.comWhy former Merck VP left big biotech for this Seattle startupDecember 10, 2024 | bizjournals.comMerck says Phase 3 KEYLYNK-001 trial met primary endpointDecember 10, 2024 | markets.businessinsider.comMerck Announces Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Advanced Epithelial Ovarian CancerDecember 10, 2024 | finance.yahoo.comMerck reports mixed results from Keytruda ovarian cancer studyDecember 10, 2024 | msn.comWhy Merck & Co. (MRK) Is Among the Best Affordable Stocks to Buy Right NowDecember 6, 2024 | msn.comMerck (NYSE:MRK) Will Pay A Larger Dividend Than Last Year At $0.81December 5, 2024 | finance.yahoo.comHere’s What is Powering Merck & Co.’s (MRK) Earnings GrowthDecember 5, 2024 | msn.comHSBC upgrades Merck stock to Buy on 2025 opportunitiesDecember 5, 2024 | msn.comMerck gets FDA Breakthrough Therapy designation for sac-TMTDecember 3, 2024 | msn.comWhy Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio’s Bridgewater Is Crazy About?December 2, 2024 | msn.comMerck KGaA (ETR:MRK) Trading 0.8% Higher - What's Next?Merck KGaA (ETR:MRK) Shares Up 0.8% - Still a Buy?November 27, 2024 | marketbeat.comMerck Phase 3 study of Winrevair in PAH meets primary endpointNovember 25, 2024 | msn.comMerck Reports Positive Topline Results From The Phase 3 ZENITH Study Evaluating WINREVAIR In PAHNovember 25, 2024 | markets.businessinsider.comMerck recommends rejection of TRC Capital’s ‘mini-tender’ offerNovember 23, 2024 | markets.businessinsider.comMerck recommends rejection of TRC Capital’s ‘mini-tender’ offerNovember 23, 2024 | markets.businessinsider.comMerck Announces Approval For WELIREG In China - Quick FactsNovember 22, 2024 | markets.businessinsider.comMerck elects Surendralal Karsanbhai to board of directorsNovember 22, 2024 | markets.businessinsider.comMerck-marketed asthma drug linked to psychiatric issues: reportNovember 22, 2024 | seekingalpha.comGoldman Sachs: Merck & Co., Inc. (MRK) Is A Top Growth Investor StockNovember 22, 2024 | msn.comMerck target upped at Jefferies after ‘important win’ with subcutaneous KeytrudaNovember 21, 2024 | markets.businessinsider.comMerck raises quarterly dividend to 81c from 77c per shareNovember 20, 2024 | markets.businessinsider.comMerck announces ‘positive’ results from Phase 3 MK-3475A-D77 trialNovember 19, 2024 | markets.businessinsider.comJ.P. Morgan Keeps Their Buy Rating on Merck KGaA (0O14)November 18, 2024 | markets.businessinsider.com Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address MRK Media Mentions By Week MRK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.200.63▲Average Medical News Sentiment MRK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼43▲MRK Articles Average Week Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MorphoSys News Today ad pepper media International News Today Genfit News Today Evotec News Today Siemens Healthineers News Today Bayer Aktiengesellschaft News Today Fresenius Medical Care News Today Carl Zeiss Meditec News Today Gerresheimer News Today CompuGroup Medical SE & Co. KGaA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MRK) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRK Stock Alerts